Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Namisol (delta-9-tetrahydrocannabinol) for behavioural disturbances and pain in dementia
2011-005289-39Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium oxybate in Alzheimer's disease (AD), vascular dementia, Dementia, sponsored by Radboud University Medical Center. Started Mar 2012; status: completed.
02
Drugs
sodium oxybate
03
Conditions
Alzheimer's disease (AD)vascular dementiaDementia
Beyond the preview
Go deeper on 2011-005289-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005289-39.